Showing results (1631-1640 of 4,056) with videos related to

Sort By:
Pageof 406
Translational Cancer Research|January 9, 2026
Prognostic chromatin remodeling signature stratifies survival outcomes in lung adenocarcinoma patientsXiongwei Wang, Yuying Liu, Danhe Huang, et al.
Translational Cancer Research|February 12, 2026
The WT 1-AS/miR-206 axis regulates the proliferation and migration of breast cancer through the cuproptosis related gene BCL11AJiasi Li, Huiliang Yang, Renwu Liu
Translational Cancer Research|February 12, 2026
A Cori cycle-related gene signature predicts prognosis, immune microenvironment, and drug response in breast cancerXiang Fang, Hongchang Tang, Kewang Sun, et al.
Translational Cancer Research|February 12, 2026
Efficacy and safety of neoadjuvant chemotherapy combined with concurrent chemoradiotherapy and concurrent chemoradiotherapy alone in locally advanced cervical cancer: a systematic review and meta-analysisYaqiong Lu, Jing Zhao, Zhihong Jia, et al.
Translational Cancer Research|February 12, 2026
Integrative machine learning of hypoxia and centrosome-related gene signatures enables prognostic stratification and therapeutic insights in lung adenocarcinomaZexia Zhao, Hui Du, Chaoyi Jia, et al.
Translational Cancer Research|February 12, 2026
Therapeutic application of IL-12 for cancer therapyZhiqing Qi, John Maher
Translational Cancer Research|February 12, 2026
Multi-omics analysis links FERMT1 expression to patient survival, immunotherapy response, and metastasis across cancersPei Chen, Lu Xiao, Chaoxiang Lv, et al.
Translational Cancer Research|February 12, 2026
CREM regulates the tumor immune microenvironment and predicts prognosis in thyroid carcinomaHao Ling, Guangmei Wu, Long Tang, et al.
Translational Cancer Research|February 12, 2026
The atypical kinase right open reading frame kinase 1 suppresses glioma cell growth through mammalian target of rapamycin inhibition and apoptotic signaling activationDaofei Ji, Jicheng Li, Peng Wang, et al.
Translational Cancer Research|February 12, 2026
Survival and response outcomes in patients with recurrent/metastatic head and neck cancer treated with opioids and statins: an exploratory pilot studyElihu Igbinadolor, Tyler J Kristoff, Dong M Shin, et al.
Pageof 406